Efficacy of ultra-short course chemotherapy for new smear positive drug susceptible pulmonary tuberculosis: study protocol of a multicenter randomized controlled clinical trial

BACKGROUND: Shortening the standard 6-month treatment for drug-susceptible pulmonary tuberculosis (DS-PTB) would be a major improvement for TB case management and disease control. METHODS: We are conducting a randomized, open-label, controlled, non-inferiority trial involving patients with smear-pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Mengqiu, Gao, Jingtao, Du, Jian, Liu, Yuhong, Zhang, Yao, Ma, Liping, Mi, Fengling, Li, Liang, Tang, Shenjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474865/
https://www.ncbi.nlm.nih.gov/pubmed/28629333
http://dx.doi.org/10.1186/s12879-017-2505-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474865/
https://www.ncbi.nlm.nih.gov/pubmed/28629333
http://dx.doi.org/10.1186/s12879-017-2505-7

Ejemplares similares